Clinical Trials Directory

Trials / Completed

CompletedNCT03258892

Sarcoma Treatment Guide in Improving Self-Monitoring in Patients With Sarcoma Receiving Chemotherapy

Sarcoma Treatment Guide Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This randomized pilot clinical trial studies how well the Sarcoma Treatment Guide works in improving self-monitoring in patients with sarcoma who are receiving chemotherapy. The Sarcoma Treatment Guide may help patients with sarcoma to be better informed, become more engaged with care, encourage communication, and to better manage side effects associated with chemotherapy treatments in order to improve quality of life.

Detailed description

PRIMARY OBJECTIVES: I. To evaluate whether symptom management and communication are improved in patients who are chemotherapy naive who receive a Sarcoma Treatment Guide as compared to those that have not. SECONDARY OBJECTIVES: I. To explore whether patients who have previously undergone chemotherapy benefit from a Sarcoma Treatment Guide (STG) in regard to symptom management and have improved communication between patient and providers. II. To assess patient satisfaction with using the STG at the end of the trial. OUTLINE: Patients are randomized to 1 of 2 arms. ARM A: Patients receive the STG before completing 4 courses of standard of care chemotherapy. ARM B: Patients complete 2 courses of standard of care chemotherapy and then receive the STG before completing 2 additional courses of standard of care chemotherapy.

Conditions

Interventions

TypeNameDescription
OTHEREducational InterventionReceive STG
OTHERQuality-of-Life AssessmentAncillary studies
OTHERSurvey AdministrationAncillary studies

Timeline

Start date
2017-05-16
Primary completion
2019-06-05
Completion
2020-12-15
First posted
2017-08-23
Last updated
2022-09-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03258892. Inclusion in this directory is not an endorsement.